Home » Oncolytics Expands Enrollment for Cancer Drug Late-Stage Trial
Oncolytics Expands Enrollment for Cancer Drug Late-Stage Trial
Oncolytics Biotech said it expanded enrollment in a late-stage study testing its head and neck cancer drug to determine its effects on two distinct patient groups.
Reuters
Reuters
Upcoming Events
-
07May
-
14May
-
30May